Inspiremd announces inducement grants under nasdaq listing rule 5635(c)(4)

Miami, feb. 25, 2025 (globe newswire) -- inspiremd, inc. (nasdaq: nspr), developer of the cguard™ prime carotid stent system for the prevention of stroke, today announced that the compensation committee of inspiremd's board of directors approved inducement grants to six new non-executive employees in the aggregate amount of 138,442 shares of restricted stock outside of inspiremd's 2021 equity compensation plan, with a grant date as of february 5, 2025, as an inducement material to the employees and the director entering into employment with inspiremd, in accordance with nasdaq listing rule 5635(c)(4). the inducement plan is used exclusively for the grant of equity awards to individuals who were not previously employees of inspiremd, or following a bona fide period of non-employment, as an inducement material to such individuals entering into employment with inspiremd, pursuant to nasdaq listing rule 5635(c)(4).
NSPR Ratings Summary
NSPR Quant Ranking